Skip to main content
Top
Published in: Digestive Diseases and Sciences 3/2024

10-02-2024 | Hepatic Encephalopathy | Original Article

Predictors and Outcomes of Post-transjugular Intrahepatic Portosystemic Shunt Liver Failure in Patients with Cirrhosis

Authors: Amar Mukund, Ashish Aravind, Ankur Jindal, Harsh Vardhan Tevethia, Yashwant Patidar, Shiv K. Sarin

Published in: Digestive Diseases and Sciences | Issue 3/2024

Login to get access

Abstract

Background

Post-transjugular intrahepatic portosystemic shunt (TIPS) liver failure (PTLF) is a serious complication of TIPS procedure with poor patient prognosis. This study tried to investigate the incidence of PTLF following elective TIPS procedure and evaluated possible predictive factors for the same.

Methods

A retrospective analysis of patients who underwent elective TIPS placement between 2012 and 2022 and was conducted to determine development of PTLF (≥ 3-fold bilirubin and/or ≥ 2-fold INR elevation from the baseline) within 30 days following TIPS procedure. Medical record review was done and factors predicting development of PTLF and the 90-day transplant-free survival was determined.

Results

Thirty of 352 (8.5%) patients developed PTLF within 30 days of TIPS (mean age 54.2 ± 9.8 years, 83% male). The etiology of cirrhosis was related to non-alcoholic steatohepatitis (NASH) in 50%, alcohol in 33.3%, and hepatitis B/C virus infection in 16.7% of the patients. The mean Child–Turcotte–Pugh (CTP) score was 9.5 ± 1.2 and mean model for end stage liver disease (MELD) score was 14.6 ± 4.5 at the time of admission in patients who developed PTLF. The indication for TIPS was recurrent variceal bleed in 50% (15 of 30) and refractory ascites in 46.7% (14 of 30) patients with PTLF.
Multivariate analysis identified prior HE (OR 6.1; CI 2.57–14.5, p < 0.0001) and higher baseline CTP score (OR 1.47; CI 1.07–2.04; p = 0.018) as predictors of PTLF. PTLF was associated with significantly lower 90-day transplant-free survival, as compared to patients without PTLF (40% versus 96%, p < 0.001).

Conclusion

Almost 10% of patients with cirrhosis develop post-TIPS liver failure and is associated with significant early mortality and morbidity. Higher baseline CTP score and prior HE were identified as predictors for PTLF.
Literature
2.
go back to reference Luca A, D’Amico G, La Galla R, Midiri M, Morabito A, Pagliaro L. TIPS for prevention of recurrent bleeding in patients with cirrhosis: meta-analysis of randomized clinical trials. Radiology 1999;212:411–421.CrossRefPubMed Luca A, D’Amico G, La Galla R, Midiri M, Morabito A, Pagliaro L. TIPS for prevention of recurrent bleeding in patients with cirrhosis: meta-analysis of randomized clinical trials. Radiology 1999;212:411–421.CrossRefPubMed
3.
go back to reference García-Pagán JC, Caca K, Bureau C, Laleman W, Appenrodt B, Luca A et al. Early use of TIPS in patients with cirrhosis and variceal bleeding. N Engl J Med 2010;362:2370–2379.CrossRefPubMed García-Pagán JC, Caca K, Bureau C, Laleman W, Appenrodt B, Luca A et al. Early use of TIPS in patients with cirrhosis and variceal bleeding. N Engl J Med 2010;362:2370–2379.CrossRefPubMed
4.
go back to reference Gaba RC, Lakhoo J. What constitutes liver failure after transjugular intrahepatic portosystemic shunt creation? A proposed definition and grading system. Ann Hepatol 2016;15:230–235.PubMed Gaba RC, Lakhoo J. What constitutes liver failure after transjugular intrahepatic portosystemic shunt creation? A proposed definition and grading system. Ann Hepatol 2016;15:230–235.PubMed
5.
go back to reference Rahbari NN, Garden OJ, Padbury R, Brooke-Smith M, Crawford M, Adam R et al. Posthepatectomy liver failure: a definition and grading by the International Study Group of Liver Surgery (ISGLS). Surgery 2011;149:713–724.CrossRefPubMed Rahbari NN, Garden OJ, Padbury R, Brooke-Smith M, Crawford M, Adam R et al. Posthepatectomy liver failure: a definition and grading by the International Study Group of Liver Surgery (ISGLS). Surgery 2011;149:713–724.CrossRefPubMed
6.
go back to reference Wolf DC, Siddiqui S, Rayyan Y, Rozenblit G. Emergent stent occlusion for TIPS-induced liver failure. Dig Dis Sci 2005;50:2356–2358.CrossRefPubMed Wolf DC, Siddiqui S, Rayyan Y, Rozenblit G. Emergent stent occlusion for TIPS-induced liver failure. Dig Dis Sci 2005;50:2356–2358.CrossRefPubMed
7.
go back to reference Rajesh S, George T, Philips CA, Ahamed R, Kumbar S, Mohan N et al. Transjugular intrahepatic portosystemic shunt in cirrhosis: an exhaustive critical update. World J Gastroenterol 2020;26:5561–5596.CrossRefPubMedPubMedCentral Rajesh S, George T, Philips CA, Ahamed R, Kumbar S, Mohan N et al. Transjugular intrahepatic portosystemic shunt in cirrhosis: an exhaustive critical update. World J Gastroenterol 2020;26:5561–5596.CrossRefPubMedPubMedCentral
8.
go back to reference López-Méndez E, Zamora-Valdés D, Díaz-Zamudio M, Fernández-Díaz OF, Avila L. Liver failure after an uncovered TIPS procedure associated with hepatic infarction. World J Hepatol 2010;2:167–170.CrossRefPubMedPubMedCentral López-Méndez E, Zamora-Valdés D, Díaz-Zamudio M, Fernández-Díaz OF, Avila L. Liver failure after an uncovered TIPS procedure associated with hepatic infarction. World J Hepatol 2010;2:167–170.CrossRefPubMedPubMedCentral
10.
go back to reference Vizzutti F, Arena U, Rega L, Zipoli M, Abraldes JG, Romanelli RG et al. Liver failure complicating segmental hepatic ischaemia induced by a PTFE-coated TIPS stent. Gut 2009;58:582–584.CrossRefPubMed Vizzutti F, Arena U, Rega L, Zipoli M, Abraldes JG, Romanelli RG et al. Liver failure complicating segmental hepatic ischaemia induced by a PTFE-coated TIPS stent. Gut 2009;58:582–584.CrossRefPubMed
11.
go back to reference Casadaban LC, Parvinian A, Couture PM, Minocha J, Knuttinen MG, Bui JT et al. Characterization of liver function parameter alterations after transjugular intrahepatic portosystemic shunt creation and association with early mortality. Am J Roentgenol 2014;203:1363–1370.CrossRef Casadaban LC, Parvinian A, Couture PM, Minocha J, Knuttinen MG, Bui JT et al. Characterization of liver function parameter alterations after transjugular intrahepatic portosystemic shunt creation and association with early mortality. Am J Roentgenol 2014;203:1363–1370.CrossRef
12.
go back to reference Rouillard SS, Bass NM, Roberts JP, Doherty CA, Gee L, Bacchetti P et al. Severe hyperbilirubinemia after creation of transjugular intrahepatic portosystemic shunts: natural history and predictors of outcome. Ann Intern Med 1998;128:374–377.CrossRefPubMed Rouillard SS, Bass NM, Roberts JP, Doherty CA, Gee L, Bacchetti P et al. Severe hyperbilirubinemia after creation of transjugular intrahepatic portosystemic shunts: natural history and predictors of outcome. Ann Intern Med 1998;128:374–377.CrossRefPubMed
13.
go back to reference Luca A, Miraglia R, Maruzzelli L, D’Amico M, Tuzzolino F. Early liver failure after transjugular intrahepatic portosystemic shunt in patients with cirrhosis with model for end-stage liver disease score of 12 or less: incidence, outcome, and prognostic factors. Radiology 2016;280:622–629.CrossRefPubMed Luca A, Miraglia R, Maruzzelli L, D’Amico M, Tuzzolino F. Early liver failure after transjugular intrahepatic portosystemic shunt in patients with cirrhosis with model for end-stage liver disease score of 12 or less: incidence, outcome, and prognostic factors. Radiology 2016;280:622–629.CrossRefPubMed
14.
go back to reference Yao Y, Satapathy SK, Fernandes EDSM, Ramírez-Fernández O, Vitale A, Chen Z. Hepatic venous pressure gradient (HVPG) predicts liver failure after transjugular intrahepatic portal shunt: a retrospective cohort study. Ann Transl Med 2022;10:1122.CrossRefPubMedPubMedCentral Yao Y, Satapathy SK, Fernandes EDSM, Ramírez-Fernández O, Vitale A, Chen Z. Hepatic venous pressure gradient (HVPG) predicts liver failure after transjugular intrahepatic portal shunt: a retrospective cohort study. Ann Transl Med 2022;10:1122.CrossRefPubMedPubMedCentral
15.
go back to reference Chalasani N, Clark WS, Martin LG, Kamean J, Khan MA, Patel NH et al. Determinants of mortality in patients with advanced cirrhosis after transjugular intrahepatic portosystemic shunting. Gastroenterology 2000;118:138–144.CrossRefPubMed Chalasani N, Clark WS, Martin LG, Kamean J, Khan MA, Patel NH et al. Determinants of mortality in patients with advanced cirrhosis after transjugular intrahepatic portosystemic shunting. Gastroenterology 2000;118:138–144.CrossRefPubMed
16.
go back to reference Pan JJ, Chen C, Caridi JG, Geller B, Firpi R, Machicao VI et al. Factors predicting survival after transjugular intrahepatic portosystemic shunt creation: 15 years’ experience from a single tertiary medical center. J Vasc Interv Radiol 2008;19:1576–1581.CrossRefPubMed Pan JJ, Chen C, Caridi JG, Geller B, Firpi R, Machicao VI et al. Factors predicting survival after transjugular intrahepatic portosystemic shunt creation: 15 years’ experience from a single tertiary medical center. J Vasc Interv Radiol 2008;19:1576–1581.CrossRefPubMed
17.
go back to reference Encarnacion CE, Palmaz JC, Rivera FJ, Alvarez OA, Chintapalli KN, Lutz JD et al. Transjugular intrahepatic portosystemic shunt placement for variceal bleeding: predictors of mortality. J Vasc Interv Radiol 1995;6:687–694.CrossRefPubMed Encarnacion CE, Palmaz JC, Rivera FJ, Alvarez OA, Chintapalli KN, Lutz JD et al. Transjugular intrahepatic portosystemic shunt placement for variceal bleeding: predictors of mortality. J Vasc Interv Radiol 1995;6:687–694.CrossRefPubMed
19.
go back to reference Vaquero J, Chung C, Cahill ME, Blei AT. Pathogenesis of hepatic encephalopathy in acute liver failure. Semin Liver Dis 2003;23:259–269.CrossRefPubMed Vaquero J, Chung C, Cahill ME, Blei AT. Pathogenesis of hepatic encephalopathy in acute liver failure. Semin Liver Dis 2003;23:259–269.CrossRefPubMed
20.
go back to reference Zipprich A. Hemodynamics in the isolated cirrhotic liver. J Clin Gastroenterol 2007;41:S254–S258.CrossRefPubMed Zipprich A. Hemodynamics in the isolated cirrhotic liver. J Clin Gastroenterol 2007;41:S254–S258.CrossRefPubMed
21.
go back to reference Radeleff B, Sommer CM, Heye T, Lopez-Benitez R, Sauer P, Schmidt J et al. Acute increase in hepatic arterial flow during TIPS identified by intravascular flow measurements. Cardiovasc Interv Radiol 2009;32:32–37.CrossRef Radeleff B, Sommer CM, Heye T, Lopez-Benitez R, Sauer P, Schmidt J et al. Acute increase in hepatic arterial flow during TIPS identified by intravascular flow measurements. Cardiovasc Interv Radiol 2009;32:32–37.CrossRef
22.
go back to reference Schneider AW, Kalk JF, Klein CP. Hepatic arterial pulsatility index in cirrhosis: correlation with portal pressure. J Hepatol 1999;30:876–881.CrossRefPubMed Schneider AW, Kalk JF, Klein CP. Hepatic arterial pulsatility index in cirrhosis: correlation with portal pressure. J Hepatol 1999;30:876–881.CrossRefPubMed
23.
go back to reference Bosch J, Abraldes JG, Berzigotti A, García-Pagan JC. The clinical use of HVPG measurements in chronic liver disease. Nat Rev Gastroenterol Hepatol 2009;6:573–582.CrossRefPubMed Bosch J, Abraldes JG, Berzigotti A, García-Pagan JC. The clinical use of HVPG measurements in chronic liver disease. Nat Rev Gastroenterol Hepatol 2009;6:573–582.CrossRefPubMed
25.
go back to reference Ripoll C, Groszmann R, Garcia-Tsao G, Grace N, Burroughs A, Planas R et al. Hepatic venous pressure gradient predicts clinical decompensation in patients with compensated cirrhosis. Gastroenterology 2007;133:481–488.CrossRefPubMed Ripoll C, Groszmann R, Garcia-Tsao G, Grace N, Burroughs A, Planas R et al. Hepatic venous pressure gradient predicts clinical decompensation in patients with compensated cirrhosis. Gastroenterology 2007;133:481–488.CrossRefPubMed
Metadata
Title
Predictors and Outcomes of Post-transjugular Intrahepatic Portosystemic Shunt Liver Failure in Patients with Cirrhosis
Authors
Amar Mukund
Ashish Aravind
Ankur Jindal
Harsh Vardhan Tevethia
Yashwant Patidar
Shiv K. Sarin
Publication date
10-02-2024
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 3/2024
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-023-08256-x

Other articles of this Issue 3/2024

Digestive Diseases and Sciences 3/2024 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine